No Detail Found!

Application of UV-visible spectrophotometric method for the estimation of ciprofloxacin HCl and levofloxacin hemihydrate (antibiotics) in marketed drugs

Author(s)
Mir Munsif Ali Talpur Institute of Chemistry, Shah Abdul Latif University,Khairpur, Sindh,Pakistan
Tajnees Pirzada Institute of Chemistry, Shah Abdul Latif University,Khairpur, Sindh,Pakistan
Muhammad Afzal Arain Institute of Chemistry, Shah Abdul Latif University,Khairpur, Sindh,Pakistan
Abstract
Summary: Ciprofloxacin HCl, 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin1-yl)-1,4dihydroquinoline-3-carboxylic acid, is a synthetic broad antibacterial compound belonging to the group of fluoroquinolones which is antimicrobial drug act through the inhibition of DNA-gyrase, an enzyme that is critical to bacterial chromosome replication. It is used in a wide range of infections of the urinary, respiratory and gastrointestinal tracts, as well as in skin structure and ocular infections. Levofloxacin Hemihydrate is a fluoroquinolone, has a broad-spectrum antibiotic activity against gram-positive and gram-negative bacteria and used in respiratory and urinary tract infections. Various Pakistani branded antibiotic drug samples containing Ciprofloxacin HCl and Levofloxacin Hemihydrate were collected from local market and their working standards from the material suppliers of Karachi city. Samples were analyzed by using UV-Vis spectrophotometer. Then the method was validated by linearity, accuracy, precision (reproducibility, intermediate precision) and range which suggested that method is appropriate and proper to determine the potency of these various brands of Ciprofloxacin HCl and Levofloxacin Hemihydrate. The analytical data suggest that the drug samples analyzed were within the limit of the Pharmacopeia requirement and criteria.
Publication Details
Page(s) 679-686
Published Journal: Journal of Chemical Society of Pakistan, Volume: 42, Issue: 5, Year: 2020

Request the full text from PASTIC

Keywords
UV-Vis spectroscopy, Ciprofloxacin HCl, Validation, Levofloxacin Hemihydrate, Reference solution
References
Colgan L. G.,Miller L. G. .2011 .International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis, 52 : .
Schaeffer A. J. .2002 .The expanding role of fluoroquinolones. Am J Med, 113(45) : .
Meth ,(2018) M. Mezni T.,Saied N.,Horri N. . .Removal of enrofloxacin from aqueous solutions using illite and syntheticzeolite X,” Sur. , 4596141 : 5.
Electrochem .2017 .. , 53 : 89.
.2015 .In vitro evaluation of Ciprofloxacin HCl Hydrochloride. Bangladesh J. Sci. Ind. Res, 50(251) : .
Kassab N. M.,Singh N.M.,Kedor-Hackmam A.K.,Santoro E.R.M.,Braz M.I.R.M. .2005 .. , 41(507) : .
Ullah A.,Zahoor M.,Alam S.,Ullah R.,Alqahtani and H. M. Mahmood A S. .2019 .Separation of Levofloxacin from Industry Effluents Using Novel, Magnetic Nanocomposite and Membranes Hybrid Processes. Biomed. Res. Int, 13 : .
Naveed S.,Sultana N.,Saeed M.,Dilshad A. H. .2014 .A new HPLC method for the assay of levofloxacin and its application in drug-metal interaction studies. J. Scie. Inno..Res, 3(91) : .
Indian Pharmacopoeia .2014 .. The Indian Pharmacopoeia Commission, Ghaziabad, 2 : .
United States Pharmacopeia .2013 .. The official Compendia of Standards, 3 : .
Berhe A.,Russom M.,Bahran F.,G. F. .2019 .Hagos, Ciprofloxacin and risk of hypolycemia in non-diabetic patients. Jou. Med.Case Reports, 13 : .
J. Mcquiston Haslund,Dinesen M. Rosborg,Sternhagen Nielsen A. B.,Lior C.,Bjerrum L. .2013 .Different recommendations for empiric first-choice antibiotic treatment of uncomplicated urinary tract infections in Europe. , 31(235) : .
Hawkings N. J.,Butler C. C.,Wood F.,India F. .2008 .A window on medical care in a developing country. Soc Sci. Med, 38(717) : 10.
K. R. Smith C. F.,Corvalán T.,Kjellström T. .1999 .How much global ill health is attributable to environmental factors?. Epidemiology, 10(573) : .
M. Zusso V.,Lunardi D.,Franceschini A.,Pagetta R.,Lo S.,Stifani A. C.,Frigo P.,Giusti S.,Moro S. .2019 .Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway. J. Neuroinflammation, 16(148) : .
M. K.Nájla K. S.,Anil K. S.,R. M. K. H. Erika I. R. M. S.,Maria Brazilian J.,Pharma Brazilian J. .2005 .. , 41 : .
R. K. Mahesh S. C.,Wari N. K.,Chaturvedi N. K. .2006 .Novel spectrophotometric estimation of some poorly water-soluble drugs using hydrotropic solubilizing agents. Indian J. Pharmaceutical Sci, 68(195) : .
E.E.M.E.A .2006 .Validation of Analytical Procedures: Text and Methodology Q2 (R1), EMEA. , : .
British Pharmacopoeia .2009 .Her Majesty's Stationery Office, London, I and II (. , : .
Method validation .2017 .. , 1780 : .
British Pharmacopia .2017 .. , : .
0

Citations

0

Downloads

12

Views